These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 35760059)

  • 1. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
    Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
    Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Cervical and Anal High-Risk Human Papillomavirus Infection in Women Living With HIV: An Observational Case-Control Study.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Das PK; Singh S; Gupta S
    J Acquir Immune Defic Syndr; 2022 Nov; 91(3):319-324. PubMed ID: 35916635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China.
    Duan R; Zhang H; Wu A; Li C; Li L; Xu X; Qiao Y; Zhao F; Clifford G
    Sex Transm Infect; 2022 Jun; 98(4):247-254. PubMed ID: 34187906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta-analysis.
    Gupta R; Kaur A; Sandeep ; Singh S; Gupta S
    HIV Med; 2022 Apr; 23(4):378-389. PubMed ID: 35150185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
    Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
    BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
    PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China.
    Feng RM; Z Wang M; Smith JS; Dong L; Chen F; Pan QJ; Zhang X; Qiao YL; Zhao FH
    J Clin Virol; 2018; 99-100():84-90. PubMed ID: 29396352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
    Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
    Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia.
    Megersa T; Dango S; Kumsa K; Lemma K; Lencha B
    BMC Womens Health; 2023 Mar; 23(1):125. PubMed ID: 36959649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
    Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
    BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
    Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
    Wagner A; Skof AS; Sehouli J; Richter R; Henrich W; von Weizsäcker K; Siedentopf JP; Chekerov R; Kaufmann AM; Rohr I
    Int J Gynecol Cancer; 2022 Jun; 32(6):716-723. PubMed ID: 35354606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
    Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
    Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV-1 in Lao People's Democratic Republic.
    Paboriboune P; Phongsavan K; Arounlangsy P; Flaissier B; Aphayarath O; Phimmasone P; Banchongphanith K; Xayaovong M; Jourdain G; Schott AM; Saadatian-Elahi M; Magaud L; Klich A; Ngo-Giang-Huong N; Heard I; Rabilloud M; Picot VS; Longuet C
    Cancer Med; 2022 May; 11(9):1984-1994. PubMed ID: 35257506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
    Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
    Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.